Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice
|ClinicalTrials.gov Identifier: NCT01446146|
Recruitment Status : Completed
First Posted : October 5, 2011
Last Update Posted : July 24, 2013
|Condition or disease||Intervention/treatment|
|Posttraumatic Stress Disorder (PTSD)||Behavioral: Informed decision making Behavioral: Placebo session|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||27 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Study Start Date :||October 2011|
|Primary Completion Date :||January 2013|
|Study Completion Date :||January 2013|
Experimental: IDM intervention
Will receive a 40 minute intervention session with a clinician, learning about PTSD treatment options and choosing a preferred treatment.
Behavioral: Informed decision making
40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.
Placebo Comparator: Treatment as usual plus placebo session
Will work with provider to select a treatment plan and will receive a 40 minute session without IDM intervention.
Behavioral: Placebo session
Participant will complete clinician-administered measures in a 40-minute session.
- Treatment participation [ Time Frame: 4 months ]Trauma Recovery Program service utilization as assessed by chart review.
- Treatment satisfaction [ Time Frame: 4 months ]Assessed via self-report measures (Client Satisfaction Questionnaire, Credibility/Expectancy Questionnaire) and semi-structured interview
- Change in PTSD severity [ Time Frame: Baseline and 4 months ]Assessed by the PCL-M at baseline and 4 month follow-up
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01446146
|United States, Texas|
|Michael E. DeBakey VA Medical Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Juliette M Mott, PhD||MDVAMC, BCM, SC MIRECC|